Neurol Clin. 2020 Aug;38(3):591-605. doi: 10.1016/j.ncl.2020.03.006. Epub 2020 Jun 11.
ABSTRACT
Please verify term, "alternative". Chronic immune-mediated demyelinating polyneuropathy (CIDP) is a treatable immune-related demyelinating polyneuropathy. Approximately 20% of cases do not respond to first-line therapies; most of these cases are due to alternative diagnoses, although some of them are due to severe CIDP. Unfortunately, a lack of universally accepted diagnostic criteria complicates the course of diagnosis and treatment. This article discusses videos of cases referred to a tertiary medical center for "refractory CIDP" and pitfalls in the diagnosis and management of this condition.
PMID:32703471 | DOI:10.1016/j.ncl.2020.03.006